Skip to main content
. 2020 Nov 25;28(5):242–247. doi: 10.1136/ejhpharm-2020-002449

Table 1.

Numbers of COVID-19 patients, prescriptions and pharmaceutical interventions, University Hospital of Strasbourg, France

All targeted medications Lopinavir/
ritonavir
Hydroxychloroquine Azithromycin
Number of patients 278* 76 140† 152†
Baseline patients characteristics Mean (SD) age: 59.9±14.8 years
Female n=112 (40.3%), male n=166 (59.7 %); sex ratio 1.5
Number of prescriptions analysed/total number of prescriptions 483/686 79/86 214/290 190/310
Number of patients with PIs* 53 21 26 6
Baseline characteristics of the patients with PIs Mean (SD) age: 58.0±14.6 years
Female n=18 (34.0%), male n=35 (66.0 %); sex ratio 1.9

*From 1193 patients hospitalised in standard care units.

†77 patients treated with hydroxychloroquine/azithromycin combination.

PIs, pharmaceutical interventions.